Member Info for AllAtSea

I have cash waiting.

Yes it's time to move on from virus testing. A very small part of what TTG is about.

I'm out. Needed the cash and couldn't wait. Cleared £50!

Should dividend chasers look elsewhere? Selling on top of a healthy rise must enable some cut price bargains to be had?

It just depends on how much trust can be had in NXT mgt. Maybe acquisitions activity is priced in or maybe not? It would be surprising if not.

I am not too displeased with the statement.

No, couldn't resist. Back in the game..

Maybe later..

Perhaps a buying opportunity? Or maybe later?

Don't understand why this is a fixture like football teams.

I am delighted to own stocks for both. Covid has undoubtedly affected perceptions and will eventually stop muddying the waters.

Was trading AZN in 2020 and it did me well and I am finishing with a good holding that other things being equal I will hang on to for a while. Also expect GSK to perk up during 2021.

Got in low last week and very pleased to be back on board at the price. If AZN cover their development costs for the vaccine then it has to be a positive. Not unlike space travel, the benefits are in what you learn from it and they can be huge.

Held Aviva (in whatever guise) since the mid-90s. It did well at first then slumped badly and has never really recovered. But I hung on thinking it's a big company with lots under the bonnet, surely it will start to realise its potential?

A year ago I started to dump it. The dividend 'decision' was the last straw. During this year of pandemic I have been trading my Aviva cash and realised a profit over the year of just under 10% with some dividends still in the pipeline and now have a portfolio of a dozen companies with half a dozen more on the reserves bench, including AV.

If I see reason to get back into AV. I will but no more false dawns for me.

"There were 175 serious adverse events (84 in the ChAdOx1 nCoV-19 group and 91 in the control group), three of which were possibly related to the intervention: transverse myelitis occurring 14 days after a ChAdOx1 nCoV-19 booster vaccination, haemolytic anaemia in a control recipient, and fever higher than 40°C in a participant still masked to group allocation. Two additional transverse myelitis cases considered unlikely to be related to the intervention occurred: one 10 days after the first dose of ChAdOx1 nCoV-19 was attributed to pre-existing multiple sclerosis and one in a control group that occurred 68 days after vaccination. The transverse myelitis cases resulted in temporarily pausing the trial and all participants have recovered or are recovering."

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32623-4/fulltext

Yeah, was expecting a nice rise this morning but I have a balanced portfolio: when half goes up the other half goes down.

I should learn to expect nothing.

This link might work
https://app.ft.com/content/0ad28950-cf97-4ae9-8b08-18fdc9ffbeb1

Boost for Astrazeneca and Glaxosmithkline: Drug giants to be at heart of post-Brexit UK

https://www.thisismoney.co.uk/money/markets/article-9076515/Drug-giants-heart-post-Brexit-UK.html

It's not so far fetched I suppose.

Bought back in this a.m. at 7348.

Let's what happens this pm. Buying late Friday can be a good move

Top-sliced profits from RDSB today before they could drop again. ULVR looks a good bet now I have cash.

No Walter Mitty here. I am 63.15% up on MNG this morning, having bought stock in March. Also got into XPP at 2998 early April now 4360. Also traded OCDO, ULVR and PRTC. I sold most of my AV. in December, January and February.